Howard A. Rockman, MD, is the Editor in Chief of JCI Insight. He is also the Edward S. Orgain Professor of Cardiology and Professor of Medicine in the Department of Cell Biology and the Department of Molecular Genetics at Duke University Medical Center. He received his MD from McGill University and completed medical residency at the Montreal General Hospital, followed by a cardiology fellowship at the University of California, San Diego. His primary research interests are focused on understanding the molecular mechanisms of cardiac hypertrophy and heart failure. His laboratory has studied the role of G protein–coupled receptors (GPCRs) in the development of disease and uncovered GPCR/β-arrestin–dependent signaling that is independent of G protein activation in regulating cardiac function. Dr. Rockman is a member of the American Society for Clinical Investigation (profile) and the Association of American Physicians. He was Editor in Chief of JCI from 2012 to 2017. Dr. Rockman has declared a first-tier potential conflict of interest with Trevena Inc.
Rodger A. Liddle, MD, is an Associate Editor for JCI Insight. He is also Professor of Medicine at Duke University Medical Center. His research focuses on the regulation of gastrointestinal hormone secretion, pancreatic physiology, and experimental models of pancreatitis. Dr. Liddle’s lab established an assay for measuring blood levels of cholecystokinin (CCK) and studied its physiologic actions in animals and humans. These studies have been extended to isolated enteroendocrine cells, and the Liddle lab has discovered that hormone-secreting cells of the GI tract have axon-like basal processes that communicate with neurons. Dr. Liddle’s other laboratory interests pertain to experimental models of pancreatitis, including the role of trypsin and trypsin inhibitors in the pathogenesis of pancreatitis and the role of neurogenic influences on pancreatic inflammation. Dr. Liddle is a member of the American Society for Clinical Investigation (profile) and the Association of American Physicians. Dr. Liddle served as Associate Editor of Gastroenterology, Senior Associate Editor of the American Journal of Physiology, and Associate Editor of the JCI prior to his appointment to JCI Insight. He has declared no financial conflicts of interest.
Yiping Yang, MD, PhD, is an Associate Editor for JCI Insight. He is also Professor of Medicine in the Division of Hematologic Malignancies and Cellular Therapy at Duke University. His research focuses on tumor immunology and viral immunity. Specifically, he is interested in innate immunity to viruses, T cell memory, and mechanisms for cancer immune evasion. His long-term goal is to develop effective gene immunotherapeutic strategies for treating cancer. Dr. Yang’s clinical interests include lymphoma and EBV-associated malignancies. Dr. Yang served as Associate Editor for the JCI prior to his appointment to JCI Insight, and he is a member of the American Society for Clinical Investigation (profile). He has declared no financial conflicts of interest.
Sarah Jackson, PhD, is Executive Editor for the JCI and JCI Insight. She received her PhD in biochemistry from the University of North Carolina at Chapel Hill for her research on the function of a cullin-based ubiquitin ligase complex in cell cycle progression and the development of T and B lymphocytes. Dr. Jackson joined the JCI in March 2012 as a Science Editor. She became Senior Science Editor of the JCI in May 2013 and Executive Editor in December 2015. She has declared no financial conflicts of interest.
Corinne Williams, PhD, is a Science Editor for the JCI and JCI Insight. She received her PhD in molecular, cellular, and developmental biology from the University of California, Santa Barbara. As a graduate student in the laboratory of Peggy Cotter, she focused her research on gene regulation and virulence in bacterial respiratory pathogens of the genus Bordetella. She then joined William Goldman’s lab at the University of North Carolina at Chapel Hill, where she studied pathogenesis of the dimorphic fungus Histoplasma capsulatum. Dr. Williams joined the JCI editorial staff in July 2013. She has declared no financial conflicts of interest.